Sidley advised I-Mab on the deal. I-Mab (Nasdaq: IMAB) obtained a victory in a multi-year long dispute over two collaboration agreements between I-Mab and Tracon Pharmaceuticals...
I-Mab’s Victory in International Arbitration
Myovant Sciences’ License Agreement with Accord Healthcare
Sidley represented Myovant Sciences on the deal. Pinsent Masons represented Accord Healthcare. Myovant Sciences (NYSE: MYOV), a biopharmaceutical company focused on developing innovative treatments for women’s...
Immuneering’s US$129.4 Million IPO
Sidley Austin advised the underwriters on the deal, while Choate and Latham & Watkins assisted Immuneering Corporation. Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a...